These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36757183)

  • 21. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
    Mao X; Ke Z; Shi X; Liu S; Tang B; Wang J; Huang H
    Ann Clin Lab Sci; 2015; 45(5):533-44. PubMed ID: 26586705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
    Zimenkov DV; Kulagina EV; Antonova OV; Surzhikov SA; Bespiatykh IuA; Shitikov EA; Il'ina EN; Mikhaĭlovich VM; Zasedatelev AS; Griadunov DA
    Mol Biol (Mosk); 2014; 48(2):251-64. PubMed ID: 25850294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
    Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
    BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
    Varghese B; Al-Hajoj S
    Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.
    Georghiou SB; Seifert M; Lin SY; Catanzaro D; Garfein RS; Jackson RL; Crudu V; Rodrigues C; Victor TC; Catanzaro A; Rodwell TC
    BMC Infect Dis; 2016 Aug; 16(1):458. PubMed ID: 27576542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
    Click ES; Kurbatova EV; Alexander H; Dalton TL; Chen MP; Posey JE; Ershova J; Cegielski JP
    J Infect Dis; 2020 Jun; 221(12):2072-2082. PubMed ID: 32002554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
    Habibnia S; Karami-Zarandi M; Zaker S; Ghalavand Z; Doustdar F; Eslami G; Kazemian H
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
    Georghiou SB; Magana M; Garfein RS; Catanzaro DG; Catanzaro A; Rodwell TC
    PLoS One; 2012; 7(3):e33275. PubMed ID: 22479378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.
    Havlicek J; Dachsel B; Slickers P; Andres S; Beckert P; Feuerriegel S; Niemann S; Merker M; Labugger I
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29212699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
    Kateete DP; Kamulegeya R; Kigozi E; Katabazi FA; Lukoye D; Sebit SI; Abdi H; Arube P; Kasule GW; Musisi K; Dlamini MG; Khumalo D; Joloba ML
    BMC Pulm Med; 2019 Jul; 19(1):124. PubMed ID: 31291943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Campbell PJ; Morlock GP; Sikes RD; Dalton TL; Metchock B; Starks AM; Hooks DP; Cowan LS; Plikaytis BB; Posey JE
    Antimicrob Agents Chemother; 2011 May; 55(5):2032-41. PubMed ID: 21300839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.
    Hu Y; Hoffner S; Wu L; Zhao Q; Jiang W; Xu B
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3857-63. PubMed ID: 23733477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa.
    Olawoye IB; Uwanibe JN; Kunle-Ope CN; Davies-Bolorunduro OF; Abiodun TA; Audu RA; Salako BL; Happi CT
    Sci Rep; 2021 Aug; 11(1):17387. PubMed ID: 34462504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
    Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to
    Omar SV; Louw G; Ismail F; Liu X; Ngcamu D; Gwala T; van der Meulen M; Joseph L
    J Clin Microbiol; 2024 Aug; 62(8):e0022924. PubMed ID: 39058018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Zhao LL; Chen Y; Liu HC; Xia Q; Wu XC; Sun Q; Zhao XQ; Li GL; Liu ZG; Wan KL
    Antimicrob Agents Chemother; 2014; 58(4):1997-2005. PubMed ID: 24419342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of
    Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices.
    Gomgnimbou MK; Hernández-Neuta I; Panaiotov S; Bachiyska E; Palomino JC; Martin A; del Portillo P; Refregier G; Sola C
    J Clin Microbiol; 2013 Nov; 51(11):3527-34. PubMed ID: 23966495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.